• 제목/요약/키워드: zeranol

검색결과 7건 처리시간 0.02초

근육 식품 중의 diethylstibestrol과 zeranol 분석법 (Analytical Methods for Diethylstibestrol and Zeranol in Muscle Foods)

  • 하재호
    • 한국식품과학회지
    • /
    • 제34권3호
    • /
    • pp.385-389
    • /
    • 2002
  • 성장 촉진 호르몬제인 DES와 zeranol의 분석을 위한 조건을 검토한 결과는 다음과 같다. 질량분석기의 SIM에서 선택한 이온 중 DES는 $M^+$ 416, $D_8DES$$M^+$ 420, ${\beta}-estradiol$$M^+$ 416, zeranol은 $M^+$ 433이 가장 좋은 응신비를 나타내었고 이들 이온을 선택할 경우 효율적으로 분석이 가능하였다. 강 음이온 교환수지인 Dowex $2{\times}8$, 400 mesh 칼럼 1 cc에 통과시킨 경우 방해물질이 효율적으로 제거되었고 회수율이 가장 높았다. $D_8DES$을 내부표준물질로 사용하여 회수율을 측정한 결과 DES는 $85{\sim}110%$이었고, zeranol은 $75{\sim}110%$이었으며 ${\beta}-estradiol$을 내부표준물질로 사용한 경우 DES의 회수율은 $82{\sim}105%$, zeranol은 $65{\sim}120%$이었다. 또한 $D_8DES$ 대신에 ${\beta}-estradiol$을 내부표준물질로 사용하여 DES와 zeranol을 분석하는 것이 가능하였다. DES와 zeranol의 LOD를 측정한 결과 각각 0.05 ng/g, 0.2 ng/g었으며 LOQ를 측정할 결과 DES는 0.5 ng/g, zeranol은 1.0 ng/g이었다. 국내산과 수입산 쇠고기, 국내산 돼지고기, 닭고기, 오리고기, 양식광어와 양식 송어를 분석한 결과 DES와 zeranol은 잔류되지 않았다.

Gas Chromatography/Mass Spectrometry에 의한 우육 중의 잔류 Zeranol, Zearalenone 및 그 대사산물들의 동시 분석법에 대한 연구 (A Study on the Simultaneous Determination of Residual Zeranol, Zearalenone and Their Metabolites in Beef by Gas Chromatography/Mass Spectrometry)

  • 이은섭;이용욱
    • 한국식품위생안전성학회지
    • /
    • 제9권1호
    • /
    • pp.1-13
    • /
    • 1994
  • A Simultaneous determination method was improved for the determination and confirmation of zeranol, zearalenone, as well as their isomers and metabolites, in beef. The analytes were extracted from tissue by CH3CN, hydrolyzed enzymatically(for glucuronide conjugates), cleaned up by a strong basic anion exchange resin combined with a liquid/liquid partitioning, derivatized using MSTFA and confirmed, quantified by GC/MS/SIM with a internal standard, zearalane. The results were as follows : (1) all the estrogens were separated on the GC/MS chromatogram under the extraction method and the chromatographic conditions improved, the retention times of zearalane-TMS2, zearalanone-TMS2, zearalenone-TMS2, zeranol-TMS3, taleranol-TMS3, and $\alpha$-zearalenol-TMS3, $\beta$-zearalenol-TMS3, were 18.49, 19.44, 19.63, 19.71, 19.79 and 19.99, 20.08 minutes, respectively. (2) The calibration curves of residual zeranol, zearalenone and their metabolites showed constantly linear(r=0.99) in the range of 5~20 ng. The minimum detection concentration of residual zeranol, zearalenone and their metabolites was 1 ppb. (3) The total average recovery of residual zeranol, zearalenone and their metabolites from spiked beef was 60.2%(CV=29.7%) at the 1 ppb and 63.5%(CV=26.5) at the 2 ppb, 72.9%(CV=18.2%) at the 4 ppb. (4) The preservation method for 6 estrogens was improved for the fast running time(21 min) and MSTFA was utilized for derivatizing 6 estrogens for improvement of recovery, for good resolution, for characteristic mass spectra unlike Jose's method and Tina's method. The utilization of zearalane as internal standard showed good quantification result for zeranol, zearalenone, as well as their isomers and metabolites, in beef.

  • PDF

Effects of Feeding Monensin in Combination with Zeranol Implants on Performance, Carcass Traits and Nutrient Digestibility of Growing Lambs

  • Owaimer, A.N.;Kraidees, M.S.;Al-Saiady, M.;Zahran, S.;Abouheif, M.A.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제16권9호
    • /
    • pp.1274-1279
    • /
    • 2003
  • Thirty-six Naeimi ram lambs were equally and randomly allotted to four treatment groups with three replications per treatment to determine the simple and additive effects of monensin and zeranol on growth performance, carcass characteristics and nutrient digestibility. The treatment groups were: basal diet-fed lambs (C), monensin-fed lambs (M) where the basal diet was supplemented with 33 mg monensin per kilogram DM, lambs implanted with 12 mg zeranol (Z), and monensin-fed lambs implanted with zeranol (MZ). Lambs fed monensin-containing diet consumed 10.5% less (p<0.05) DM/100 kg weight and were 8.3% more (p<0.05) efficient in converting feed than lambs fed control diet. Zeranol implanted lambs tended to grow 35.2% (p<0.05) faster, consumed 5.1% more (p<0.05) feed and were (p<0.05) 21.9% more efficient in their feed conversion than control lambs. Responses of lambs to monensin and zeranol implants were not additive. Except for Z treatment, there were no marked differences in all carcass characteristics among the various treatment groups. Z-lambs produced 12.7% heavier (p<0.05) carcasses compared with those from C treatment. Also fat parameters, namely, kidney and pelvic fat (KP), body wall thickness and fat thickness, indicated trends for higher finish in Z treatment lambs (p<0.05) than for those lambs from other treatments. Except for CF and ADF, no significant differences in nutrients digestibility were noticed between various treatments; feeding monensin resulted in 24.5% and 8.5% depressions (p<0.05) in CF and ADF digestibility, respectively in comparison to C treatment. Nitrogen retention as percentage of total N-intakes was averaging 7.5 and 20.2% higher (p<0.05) in lambs implanted with zeranol than those fed the M and C diets, respectively.

Zeranol 투여가 홀스타인 거세우의 성장 단계별 건물 및 양분 섭취량에 미치는 영향 (Effect of Zeranol Injection on Dry Matter and Nutrient Intake Requirements at Growth Stages of Holsein Steer)

  • 김현섭;권응기;윤상기;신종서;홍병주
    • 한국초지조사료학회지
    • /
    • 제17권4호
    • /
    • pp.399-406
    • /
    • 1997
  • This research was carried out to investigate the effect of zeranol injection on dry matter(DM) and nutrient intake requirement by growth stage of early castrated bull with 3 treatments(bul1, steer, steer+zeranol) with 28 Holstein bull at National Livestock Research Institute. The main results were as follows: DM intake at growing and fatting stage was the highest in steer groups, that the highest in bull groups at finishing stage and overall mean DM intake was 5% lower at steer+zeranol groups compared to bull and steer, respectively. Net energy intake at finishing stage was the highest as 35.49 Mcal at bull groups, while overall mean net energy intake was 101 - 109% of NRC requirement without significant difference. Concentrate intake to body weight was 1.68- 1.82, 1.91 -2.08 and 1.81 -2.05% at growing, fatting and finishing stage, respectively. Overall mean concentrate intake to body weight at steer groups was 1.94%, which is 1.8 and 1.81% higher compared to bull and steer+zeranol groups, respectively. Feed conversion ratio(DM) during overall period was the worst at steer groups as 9.321g, and also net energy conversion ratio was similar to DM conversion ratio.

  • PDF

Growth Promoters and Their Effects on Beef Production - Review -

  • Song, M.K.;Choi, S.H.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제14권1호
    • /
    • pp.123-135
    • /
    • 2001
  • Application of growth promoters by means of implantation or supplementation to the diets has been routine in the beef cattle industry of many countries for the better performance in growth and improvement of feed efficiency. Anabolic implants (zeranol, trenbolone acetate, and estradiol with testosterone or progesterone) have generated various positive effects. Zeranol implantation, in general, improved average daily gain (ADG), feed conversion (FC), dressing percentage (DP) and yield grade (YG) of cattle, and increased dry matter intake (DMI). Trenbolone acetate with or without estradiol also increased mean values of ADG and loin eye area (LEA) but reduced DMI and improved FC of cattle. Estradiol with testosterone or progesterone increased ADG and DMI. Anabolic implants, however, had minimal or negative effects on marbling or quality grade. The magnitude of the response to these anabolic implants in performance of beef cattle has varied depending on the type of implants, amount and duration of exposure, age of animals and combination of implants. Administration of bovine somatotropin improved ADG and FC, and decreased fat deposition. Ionophores improved FC in cattle from reduced DMI without great response to ADG. Supplementation of monensin and lasalocid reduced molar proportion of propionate. Monensin and lysocellin increased apparent absorption and retention of some minerals in cattle. Despite the improved cattle performance in growth and FC, results in beef quality from the application of the growth promoters appeared to vary or in conflict under a variety of environmental conditions.

육류 식품중 호르몬 성분의 분석 (Determination of hormonal active compounds in meat)

  • 서정주
    • 분석과학
    • /
    • 제21권6호
    • /
    • pp.526-534
    • /
    • 2008
  • 가축의 생산성 향상을 위해 투여될 수 있는 천연호르몬과 합성 호르몬제 등의 내분비계장애물질에 대하여 기존의 분석 방법을 개선 및 확립하고, 이를 토대로 국내에 유통 중인 육류 및 내장부위 중소간에 대해 호르몬 성분의 분포정도를 확인하였다. Estrogens ($17{\beta}$-estradiol, $17{\alpha}$-estradiol, estrone), androgens ($17{\beta}$-testosterone, $17{\alpha}$-testosterone), gestagens (progesterone)의 천연호르몬 6종과 합성호르몬 3종 DES, RALs (zeranol, taleranol)을 모니터링 대상 호르몬으로 GC-MS로 분석하였으며, 이로부터 호르몬의 background level을 측정하고, 상대적으로 호르몬제 등이 잔류될 수 있는 간 등의 장기에 대한 분포조사를 실시하였다. 전체 150건의 시료 중 합성 호르몬제는 검출되지 않았으며, 천연호르몬제는 내인성으로 존재하는 progesterone이 일반적인 농도 범위를 보였다.

Risk Assessment of Growth Hormones and Antimicrobial Residues in Meat

  • Jeong, Sang-Hee;Kang, Dae-Jin;Lim, Myung-Woon;Kang, Chang-Soo;Sung, Ha-Jung
    • Toxicological Research
    • /
    • 제26권4호
    • /
    • pp.301-313
    • /
    • 2010
  • Growth promoters including hormonal substances and antibiotics are used legally and illegally in food producing animals for the growth promotion of livestock animals. Hormonal substances still under debate in terms of their human health impacts are estradiol-$17\beta$, progesterone, testosterone, zeranol, trenbolone, and melengestrol acetate (MGA). Many of the risk assessment results of natural steroid hormones have presented negligible impacts when they are used under good veterinary practices. For synthetic hormonelike substances, ADIs and MRLs have been established for food safety along with the approval of animal treatment. Small amounts of antibiotics added to feedstuff present growth promotion effects via the prevention of infectious diseases at doses lower than therapeutic dose. The induction of antimicrobial resistant bacteria and the disruption of normal human intestinal flora are major concerns in terms of human health impact. Regulatory guidance such as ADIs and MRLs fully reflect the impact on human gastrointestinal microflora. However, before deciding on any risk management options, risk assessments of antimicrobial resistance require large-scale evidence regarding the relationship between antimicrobial use in food-producing animals and the occurrence of antimicrobial resistance in human pathogens. In this article, the risk profiles of hormonal and antibacterial growth promoters are provided based on recent toxicity and human exposure information, and recommendations for risk management to prevent human health impacts by the use of growth promoters are also presented.